🔗 Share this article

Texas Attorney General Paxton is taking legal action against the makers of Tylenol, alleging the corporations concealed potential risks that the medication posed to pediatric neurological development.

This legal action arrives four weeks after Donald Trump publicized an unverified association between taking Tylenol - referred to as paracetamol - throughout gestation and autism in young ones.

Paxton is filing suit against the pharmaceutical giant, which previously sold the drug, the exclusive pain medication suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "misled consumers by gaining financially from discomfort and promoting medication without regard for the potential hazards."

The manufacturer asserts there is insufficient reliable data connecting Tylenol to autism spectrum disorder.

"These companies deceived for years, intentionally threatening countless individuals to boost earnings," the attorney general, from the Republican party, said.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its website, the company also mentioned it had "regularly reviewed the applicable studies and there is no credible data that indicates a established connection between consuming acetaminophen and autism."

Associations speaking for medical professionals and health professionals agree.

ACOG has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for expectant mothers to treat pain and elevated temperature, which can pose significant medical dangers if not addressed.

"In over twenty years of studies on the consumption of paracetamol in pregnancy, not a single reputable study has successfully concluded that the use of acetaminophen in any stage of pregnancy leads to brain development issues in children," the association stated.

This legal action references recent announcements from the previous government in asserting the medication is reportedly hazardous.

Recently, the former president generated worry from medical authorities when he instructed expectant mothers to "struggle intensely" not to consume Tylenol when ill.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the usage of acetaminophen, while also mentioning that "a proven link" between the drug and autism in children has not been established.

The Health Department head RFK Jr, who manages the FDA, had pledged in spring to conduct "a massive testing and research effort" that would determine the cause of autism in a limited time.

But experts advised that discovering a sole reason of autism - considered by experts to be the result of a complex mix of inherited and external influences - would not be simple.

Autism is a category of lifelong neurodivergence and disability that impacts how people experience and relate to the world, and is recognized using medical professional evaluations.

In his legal document, the attorney general - who supports Trump who is running for federal office - claims the manufacturer and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

This legal action aims to force the companies "remove any marketing or advertising" that claims Tylenol is safe for expectant mothers.

The court case mirrors the grievances of a group of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

A federal judge dismissed the case, declaring investigations from the parents' expert witnesses was lacking definitive proof.